September 2020 | AIChE

You are here

September 2020

Katrina Brockbank

Katrina Brockbank, PhD, is the head of laboratory at Freeman Technology, where she has worked since 2012. She is responsible for laboratory management and research and development. Brockbank has a PhD in powder flow characterization from the Univ. of Bradford in the U.K. While completing her thesis, she also undertook several projects on pharmaceutical formulation at the university’s Institute of Pharmaceutical Innovation.Read more

Jamie Clayton

Jamie Clayton is the operations director at Freeman Technology. He is responsible for the overall management of company activities, including research and development, production, sales, and customer support teams. During his time with the company, he has worked as a mentor with several academic groups. He is an active member of the American Society of Testing and Materials (ASTM) F42 technical committee. Clayton is also a regular contributor to conferences and workshops on the topic of powder rheology and works closely with clients on the application of the company’s technology. He has a...Read more

Trent Northen

Trent Northen, PhD, is a senior scientist at Lawrence Berkeley National Laboratory (LBNL), and he is the Metabolomics Program Lead at the Joint Genome Institute (JGI) (Email: trnorthen@lbl.gov). He has pioneered EcoFAB and metabolomics technologies to understand metabolic exchanges between soil microbes, for which he has received numerous awards, including a Presidential Early Career Award for Scientists and Engineers (PECASE) from President Obama. He received his BS in chemical engineering from the Univ. of California, Santa Barbara, and his...Read more

Sebastien Guery

Sebastien Guery, PhD, leads the human microbiome venture for DuPont Nutrition and Biosciences and the global technology and innovation function. He is responsible for building the pipeline of microbiome solutions for human applications and acquiring any missing capabilities. Previously, Guery held roles in the pharmaceutical sector ranging from R&D to business development. In the past 15 years, he has worked in ten different countries, including emerging markets. He holds a PhD and a PharmD from Louis Pasteur Univ., Strasbourg, France, and an MBA from IMD in Lausanne, Switzerland.Read more

Pierre Cans

Pierre Cans, PhD, is a manufacturing and supply chain leader of probiotics, cultures food protection, and fibers at Dupont Nutrition and Biosciences. He graduated from National Institute of Applied Sciences in Toulouse, France, with a PhD in microbiology and an undergraduate degree in biochemical engineering. Since 2003, he has led global industrial operations for living microorganisms, fermentation metabolites, and enzymes production, as well as natural products extraction. He was awarded the Rhône-Poulenc Research prize.   

...Read more

Eloi Fontaine

Eloi Fontaine leads process R&D and manufacturing technology for health and biosciences at Dupont Nutrition and Biosciences. His team is responsible for new product introductions, new process development, and continuous improvements. He has more than 20 years of experience in industrial microbiology, fermentation development, and upscaling biotech processes. Fontaine holds a master’s degree in biochemical engineering from École de Biologie Industrielle, France.Read more

Claus Lindvald Johansen

Claus Lindvald Johansen, PhD, is a technical fellow of manufacturing technology and process R&D at DuPont Nutrition and Bio­sciences. He has more than 25 years of experience in directing process development and scale-up in the food industry for microbial-based products, including enzymes, human milk oligosaccharides (HMOs), and probiotics. For the past three years, he has been involved in the development of manufacturing processes for next-generation probiotics, which have the potential to become commercial live biotherapeutic products (LBPs). He holds MSc and PhD degrees in chemical...Read more

Jonathan W. Kotula

Jonathan W. Kotula, PhD, is an expert in synthetic biology and host-microbial interactions, with over 15 years of research and development experience. He is the head of science at Felix Biotechnology, Inc. He has led interdisciplinary teams of researchers to develop tools for bacterial genome editing for therapeutic purposes, has initiated research programs at biotechnology companies including Synlogic, Inc., and Caribou Biosciences, Inc., and is an inventor on several bacterial engineering patents. He has been invited to speak about his research at universities, museums, conferences, and...Read more

Pages